CERUS CORP Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings
CERUS CORP (CERS) reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings of -$3.57 million for the 12-month period ending 2015-12-31, per its 10-K filed 2017-03-08.
Discontinued › Income Statement › Other Income
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings · last filed 2017-03-08
- CERUS CORP fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for the quarter ending 2015-12-31 was $1.13M, a 82.73% decline year-over-year.
- CERUS CORP fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for the quarter ending 2015-09-30 was -$1.11M.
- CERUS CORP fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for the quarter ending 2015-06-30 was $2.71M.
- CERUS CORP fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for the quarter ending 2015-03-31 was -$6.30M.
- CERUS CORP fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for fiscal 2015 was -$3.57M.
- CERUS CORP fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for fiscal 2014 was -$7.71M, a 151.05% decline from fiscal 2013.
- CERUS CORP fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for fiscal 2013 was $15.10M.
- CERUS CORP fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for fiscal 2012 was -$2.06M.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 3 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 6 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 9 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 12 month |
|---|---|---|---|---|
| 2015-12-31 | $1.13M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-08 | $23.00K derived: sum of 2 quarters · filed 2017-03-08 | $2.73M derived: sum of 3 quarters · filed 2017-03-08 | -$3.57M 10-K · filed 2017-03-08 |
| 2015-09-30 | -$1.11M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | $1.60M derived: sum of 2 quarters · filed 2015-11-06 | -$4.70M 10-Q · filed 2015-11-06 | $1.86M derived: sum of 4 quarters · filed 2016-03-09 |
| 2015-06-30 | $2.71M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | -$3.59M 10-Q · filed 2015-08-07 | $2.97M derived: sum of 3 quarters · filed 2016-03-09 | $1.23M derived: sum of 4 quarters · filed 2016-03-09 |
| 2015-03-31 | -$6.30M 10-Q · filed 2015-05-08 | $259.00K derived: sum of 2 quarters · filed 2016-03-09 | -$1.48M derived: sum of 3 quarters · filed 2016-03-09 | -$4.97M derived: sum of 4 quarters · filed 2016-03-09 |
| 2014-12-31 | $6.55M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-09 | $4.82M derived: sum of 2 quarters · filed 2016-03-09 | $1.33M derived: sum of 3 quarters · filed 2016-03-09 | -$7.71M 10-K · filed 2016-03-09 |
| 2014-09-30 | -$1.74M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | -$5.23M derived: sum of 2 quarters · filed 2014-11-07 | -$14.26M 10-Q · filed 2014-11-07 | -$15.97M derived: sum of 4 quarters · filed 2015-03-16 |
| 2014-06-30 | -$3.49M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-08 | -$12.53M 10-Q · filed 2014-08-08 | -$14.23M derived: sum of 3 quarters · filed 2015-03-16 | -$1.81M derived: sum of 4 quarters · filed 2015-03-16 |
| 2014-03-31 | -$9.03M 10-Q · filed 2014-05-12 | -$10.74M derived: sum of 2 quarters · filed 2015-03-16 | $1.68M derived: sum of 3 quarters · filed 2015-03-16 | $992.00K derived: sum of 4 quarters · filed 2015-03-16 |
| 2013-12-31 | -$1.70M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | $10.71M derived: sum of 2 quarters · filed 2015-03-16 | $10.03M derived: sum of 3 quarters · filed 2015-03-16 | $15.10M 10-K · filed 2015-03-16 |
| 2013-09-30 | $12.42M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-01 | $11.73M derived: sum of 2 quarters · filed 2013-11-01 | $16.80M 10-Q · filed 2013-11-01 | $14.83M derived: sum of 4 quarters · filed 2014-03-07 |
| 2013-06-30 | -$686.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-02 | $4.39M 10-Q · filed 2013-08-02 | $2.41M derived: sum of 3 quarters · filed 2014-03-07 | $1.54M derived: sum of 4 quarters · filed 2014-03-07 |
| 2013-03-31 | $5.07M 10-Q · filed 2013-05-03 | $3.10M derived: sum of 2 quarters · filed 2014-03-07 | $2.23M derived: sum of 3 quarters · filed 2014-03-07 | |
| 2012-12-31 | -$1.97M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-07 | -$2.85M derived: sum of 2 quarters · filed 2014-03-07 | -$2.06M 10-K · filed 2014-03-07 | |
| 2012-09-30 | -$873.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08 | -$86.00K 10-Q · filed 2012-11-08 | ||
| 2012-06-30 | $787.00K 10-Q · filed 2012-08-08 | |||
| 2011-12-31 | -$486.00K 10-K · filed 2013-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Orthofix Medical Inc. (OFIX) | $0.373B |